Literature DB >> 10824043

Chemotherapy for upper gastrointestinal tumours.

A L Thomas1, K O'Byrne, W P Steward.   

Abstract

The aim of this review is to identify current chemotherapy treatment for tumours of the oesophagus, stomach, pancreas, and liver. The role of both neoadjuvant, adjuvant, and palliative chemotherapy regimens will be discussed. This review will be of interest to oncologists in clarifying current issues regarding chemotherapy, and to physicians in other medical specialties, to increase their general understanding of benefits and drawbacks of chemotherapy in this patient group.

Entities:  

Mesh：

Year:  2000        PMID： 10824043      PMCID： PMC1741601          DOI： 10.1136/pmj.76.896.321

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  29 in total

Review 1.  Clinical trials in primary hepatocellular carcinoma: current status and future directions.

Authors:  S R Nerenstone; D C Ihde; M A Friedman
Journal:  Cancer Treat Rev       Date:  1988-03       Impact factor: 12.111

2.  Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.

Authors:  J A Wils; H O Klein; D J Wagener; H Bleiberg; H Reis; F Korsten; T Conroy; M Fickers; S Leyvraz; M Buyse
Journal:  J Clin Oncol       Date:  1991-05       Impact factor: 44.544

3.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

4.  Palliation of Dysphagia of Esophageal Cancer by Endoscopic Lumen Restoration Techniques.

Authors: 
Journal:  Cancer Control       Date:  1999-01       Impact factor: 3.302

5.  Irradiation, chemotherapy and surgery in esophageal cancer: a randomized clinical study. The first Scandinavian trial in esophageal cancer.

Authors:  A P Andersen; P Berdal; F Edsmyr; S Hagen; R Hatlevoll; K Nygaard; P Ottosen; P Peterffy; H Kongsholm; K Elgen
Journal:  Radiother Oncol       Date:  1984-10       Impact factor: 6.280

6.  Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus.

Authors:  A A Forastiere; M B Orringer; C Perez-Tamayo; S G Urba; S Husted; B J Takasugi; M Zahurak
Journal:  J Clin Oncol       Date:  1990-01       Impact factor: 44.544

7.  Chemotherapy prolongs survival in inoperable pancreatic carcinoma.

Authors:  K R Palmer; M Kerr; G Knowles; A Cull; D C Carter; R C Leonard
Journal:  Br J Surg       Date:  1994-06       Impact factor: 6.939

8.  Effect of flutamide on survival in patients with pancreatic cancer: results of a prospective, randomised, double blind, placebo controlled trial.

Authors:  B A Greenway
Journal:  BMJ       Date:  1998-06-27

Review 9.  Oesophageal cancer treatment: studies, strategies and facts.

Authors:  A Wobst; R A Audisio; M Colleoni; J G Geraghty
Journal:  Ann Oncol       Date:  1998-09       Impact factor: 32.976

10.  Neoadjuvant chemotherapy for high-grade advanced gastric cancer.

Authors:  Y Yonemura; T Sawa; K Kinoshita; N Matsuki; S Fushida; S Tanaka; S Ohoyama; T Takashima; H Kimura; T Kamata
Journal:  World J Surg       Date:  1993 Mar-Apr       Impact factor: 3.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.